EMERGENT BIOSOLUTIONS INC. (EBS) Gross profit 2016–2025
EMERGENT BIOSOLUTIONS INC. (EBS) annual gross profit history from SEC filings — each fiscal year as reported.
$416.7MFY2025 · since FY2016: $362.5M → $416.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $416.7M | +15.0% |
| FY2024 | $362.3M | +14.1% |
| FY2023 | $317.6M | -17.1% |
| FY2022 | $383.0M | -57.0% |
| FY2021 | $891.3M | -3.7% |
| FY2020 | $925.2M | +37.6% |
| FY2019 | $672.5M | +46.2% |
| FY2018 | $460.1M | +23.3% |
| FY2017 | $373.2M | +3.0% |
| FY2016 | $362.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice